MPS Powered by Eureka

Current Drug Delivery

ISSN: 1567-2018 (Print)
eISSN: 1875-5704 (Online)

Current Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.

The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.

The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.

Special Issues With Active Call for Papers

Submission closes on: Mar 01, 2025
Tumor-targeted drug delivery systems

Tumor-targeted drug delivery systems present immense potential to revolutionize cancer treatment paradigms. This field, characterized by its intricate blend of material engineering, chemistry, biology, pharmacy, and pathology, constitutes a complex domain at the intersection of science and medicine. Thus, it is crucial to recognize the interdisciplinary structure of this field and promote communication among experts in various related fields from academia, clinics, and industry. The main goal of this section is to provide a comprehensive... see more

Submission closes on: Dec 31, 2024
Pioneering Drug Delivery Strategies for Enhanced Cancer Immunotherapies

The landscape of cancer treatment has been fundamentally transformed by the advent of immunotherapy, a modality that harnesses the body's immune system to recognize and combat malignant cells. Despite its remarkable successes, the full potential of cancer immunotherapy is yet to be realized, largely due to limitations in targeted delivery, systemic toxicity, and tumor microenvironment-induced resistance. This special issue, "Pioneering Drug Delivery Strategies for Enhanced Cancer Immunotherapies," aims to showcase the latest advancements and innovative... see more

Submission closes on: Dec 31, 2024
Electrospun Fibers as Drug Delivery Systems

In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for delivering both hydrophilic and hydrophobic drugs. The morphology of electrospun fibers can be customized to precisely control the release kinetics of drugs, with adjustments in... see more

Submission closes on: Dec 15, 2024
Nanoemulsions in cancer therapy

Solid tumors are characterized by leaky vascular structure, defective angiogenesis and high interstitial fluid load, providing opportunities for nanoparticles to preferentially exudate and be retained in tumors. This phenomenon is commonly referred to as the enhanced permeability and retention (EPR) effect, which is considered to be an important reason why nanoparticles can passively target tumors. Among the devised nanocarriers, nanoemulsions are currently being envisaged as an effective drug delivery approach for an array of chemotherapeutics... see more

Submission closes on: Nov 16, 2024
Recent Advances in Exosome-based Drug Delivery for Cancer Therapy

Exosomes have garnered interest in the area of drug delivery. In the past ten years, there has been an exponential increase in the number of exosome-related studies in cancer. Preclinical studies demonstrate exosomes-mediated delivery of chemotherapeutics, biologicals and natural products produce potent anticancer activity both, in vitro and in vivo. Exosome-based drug delivery systems present immense potential to revolutionize cancer treatment paradigms. The main goal of this section is to provide a comprehensive overview of... see more

Submission closes on: Nov 06, 2024
Potential of Electrospinning for Current Drug Delivery

Electrospinning is versatile polymer processing technology used for fabrication of nanofibers. Nanofibers explored for drug delivery, tissue engineering, and biomedical applications. It has unique properties of high surface area, porosity, stability, and excellent morphology. This electrospinning technology gained significant attention in recent years for due to its ability to overcomes limitations of traditional drug delivery methods. The proposed thematic issue aims to explore the potential of electrospinning technology in revolutionizing drug delivery, tissue engineering and... see more

Submission closes on: Nov 06, 2024
Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders

Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and patient outcomes. This proposed special issue aims to address these challenges by showcasing the latest advancements in Robotic and AI-based drug discovery and delivery systems... see more

Submission closes on: Sep 30, 2024
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer

The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to neoplastic sites via interaction with cell surface primer sites. The integration of nanotechnology in drug delivery holds potential for optimizing the pharmacokinetics, therapeutic efficacy, and... see more